GlassScriptPhysician profile
Betty P Lee
NPI 1174698708
$1,043.43
in general payments reported to CMS, 2019-2025
19 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $85.29 · 2021: $163 · 2022: $145 · 2023: $110 · 2024: $128 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $219.54 | 2019-2022 | |
| Abbvie INC. | $125.32 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.35 | 2019-2024 | |
| Exeltis, USA INC. | $100.47 | 2019-2024 | Slynd |
| Millicent US INC | $78.35 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Astellas Pharma US INC | $72.08 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $47.32 | 2025 | |
| Scynexis, INC. | $44.02 | 2022 | |
| Amag Pharmaceuticals, INC. | $41.16 | 2019 | |
| Hologic Sales and Service, LLC | $36.19 | 2023 | Acessa Provu System |
| 180 Medical, INC. | $24.97 | 2023 | |
| Shield Therapeutics INC | $23.51 | 2023 | Accrufer |
| Mylan Pharmaceuticals INC. | $20.54 | 2021 | |
| Aspira Women'S Health INC | $19.99 | 2024 | Ova1 |
| Exact Sciences Corporation | $17.79 | 2025 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $16.47 | 2022 | |
| Allergan, INC. | $15.23 | 2019 | |
| Evofem Biosciences, INC. | $14.80 | 2021 | |
| Lupin INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betty Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.